RenovoRx (RNXT) Convertible Debt (2021)
RenovoRx's (RNXT) quarterly Convertible Debt came in at $5.3 million in Q4 2021, little changed quarter-over-quarter from $5.3 million in Q3 2021.
Powered by 
Analysis
RenovoRx (RNXT) Convertible Debt (2021) Analysis & Trends
RenovoRx has disclosed Convertible Debt across 1 years of filings, most recently posting $5.3 million for Q4 2021.
- In Q4 2021, Convertible Debt changed N/A year-over-year to $5.3 million; the TTM figure through Dec 2021 stood at $5.3 million (changed N/A YoY), while the FY2021 annual figure was $5.3 million, changed N/A from the prior year.
- Convertible Debt came in at $5.3 million for Q4 2021 at RenovoRx, roughly flat from $5.3 million in the prior quarter.
- In the past five years, Convertible Debt ranged from a high of $5.3 million in Q3 2021 to a low of $5.3 million in Q3 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.71 Bn | 174.10 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 128.01 Bn | 122.80 Bn | 1.96 Bn |
| 3 | Medtronic | 117.20 Bn | 108.38 Bn | 6.34 Bn |
| 4 | Stryker | 104.00 Bn | 100.53 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.32 Bn | 62.78 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.95 Bn | 45.70 Bn | 1.35 Bn |
| 7 | Alcon | 32.88 Bn | 31.43 Bn | 1.68 Bn |
| 8 | Dexcom | 32.27 Bn | 30.33 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | RenovoRx | 81.83 Mn | 81.83 Mn | 766,000.00 |